A New Way of Naming Brain Tumors Changed Many Diagnoses in Colombia
Original title: Molecular Reclassification of Diffuse Gliomas: A Feasibility Study of Clinical Features and Survival Outcomes in Colombia.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was tested in people. That is the most reliable kind of research we share.
This was a look back at patient records, not a test of a treatment.
The short version
When doctors re-checked brain tumor samples with lab tests, about half got a new diagnosis.
What was studied. Doctors reviewed the records of 68 adults with diffuse gliomas in Bogota, Colombia. They re-checked each tumor using lab tests their own hospitals already had.
What they found. The diagnosis changed in 51.5% of cases after the new testing. The share called glioblastoma: A glioma that is given grade 4. Grade 4 is the highest grade there is. The tumor grows fast. Treatment usually starts soon after it is found. It often means surgery, and then radiation and chemotherapy. See the glossary rose from 48.5% to 66.2%. The share called oligodendroglioma fell from 17.6% to 11.8%.
What this means, and what it doesn't
What it could mean: These hospitals could re-check tumor types with tools they already own. A more exact tumor name can help guide care and trial choices. This study did not show that patients lived longer after the new naming.
What it doesn't mean: This is not a new treatment, and it is not a cure. It was a look back at old records, not a test of any therapy. The group was small and the lab testing was not complete. The authors say it does not prove better treatment choices or longer life.
Source: PubMed, October 17, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.